Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
:4892
4892 Stock Chart & Stats
¥596.00
¥1.00(0.23%)
At close: 4:00 PM EST
¥596.00
¥1.00(0.23%)
Day’s Range― - ―
52-Week Range¥430.00 - ¥1,412.00
Previous CloseN/A
Volume38.50K
Average Volume (3M)198.75K
Market Cap
¥5.49B
Enterprise Value¥4.54B
Total Cash (Recent Filing)¥2.70B
Total Debt (Recent Filing)¥766.00M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Nov 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-28.96
Shares Outstanding9,581,800
10 Day Avg. Volume64,090
30 Day Avg. Volume198,746
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)1.43
Price to Sales (P/S)66.83
P/FCF Ratio-4.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4892 FAQ
What was Cyfuse Biomedical K.K.’s price range in the past 12 months?
Cyfuse Biomedical K.K. lowest stock price was ¥430.00 and its highest was ¥1412.00 in the past 12 months.
What is Cyfuse Biomedical K.K.’s market cap?
Cyfuse Biomedical K.K.’s market cap is ¥5.49B.
When is Cyfuse Biomedical K.K.’s upcoming earnings report date?
Cyfuse Biomedical K.K.’s upcoming earnings report date is Nov 14, 2025 which is in 12 days.
How were Cyfuse Biomedical K.K.’s earnings last quarter?
Cyfuse Biomedical K.K. released its earnings results on Aug 14, 2025. The company reported -¥28.96 earnings per share for the quarter, missing the consensus estimate of N/A by -¥28.96.
Is Cyfuse Biomedical K.K. overvalued?
According to Wall Street analysts Cyfuse Biomedical K.K.’s price is currently Overvalued.
Does Cyfuse Biomedical K.K. pay dividends?
Cyfuse Biomedical K.K. does not currently pay dividends.
What is Cyfuse Biomedical K.K.’s EPS estimate?
Cyfuse Biomedical K.K.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyfuse Biomedical K.K. have?
Cyfuse Biomedical K.K. has 9,581,800 shares outstanding.
What happened to Cyfuse Biomedical K.K.’s price movement after its last earnings report?
Cyfuse Biomedical K.K. reported an EPS of -¥28.96 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.94%.
Which hedge fund is a major shareholder of Cyfuse Biomedical K.K.?
Currently, no hedge funds are holding shares in JP:4892
Company Description
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. is a pioneering biotechnology company based in Japan that specializes in three-dimensional (3D) bioprinting technology for regenerative medicine. The company focuses on developing innovative solutions for tissue engineering, particularly in the creation of complex tissue structures that can be used for transplantation and therapeutic applications. Cyfuse's core products include its proprietary 3D bioprinter and bio-inks that enable the fabrication of living tissues, which are aimed at addressing unmet medical needs in various fields such as orthopedics, cardiology, and wound healing.
Technical Analysis
Solasia Pharma KK
―
Morishita Jintan Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Medrx Co., Ltd.
―
Modalis Therapeutics Corporation
―